Our mission at Prudentia Sciences

Accelerate investment in breakthrough therapies that change the world

Prudentia closes the information gap between buyers and sellers before diligence begins.

Prudentia Sciences Team

A team of experts, scientists, and technologists who have assessed assets, built companies, and seen how decisions actually get made.

CEO & Founder

CTO

Head of Strategy

Head of Partnerships

Scientific Lead

Scientific and clinical leaders ensuring every evaluation reflects how therapies are actually understood, developed, and advanced.

Coefficient Bio, Ironwood Pharmaceuticals, Science Exchange

Eli Lilly, Veeva, Third Rock Ventures, Tesaro (acquired)

Allergan, Bayer, Formation Bio

Merida Biosciences, Cerevel Therapeutics

Operators and investors grounding Prudentia in how decisions get made: where science, capital, and deal dynamics meet.

General Atlantic, Kymera Therapeutics, Affnivax, Praxis

Shaper Capital, Datavant, LiveRamp

General Atlantic, Parexel, Helio Vision, Inc.

Leading investors supporting the future of life sciences